Partners that Unleash ADC Potential
AJICAP™ combines proven conjugation technology with a qualified network of global CDMO partners to support ADC development from early evaluation through clinical manufacturing. AJICAP™ provides technology, process development, and technology transfer support, while GMP manufacturing is performed by qualified partner CDMOs. This model provides access to established manufacturing capabilities while maintaining flexibility in development and supply.
What Sets Our Network Apart
Seamless Technology Transfer
AJICAP™ supports efficient technology transfer from process development to GMP manufacturing through well-established transfer packages and technical collaboration with qualified CDMO partners. Process knowledge, analytical methods, and manufacturing considerations are shared to facilitate a smooth transition while reducing development timelines and manufacturing risk.
Global Regulatory Alignment
AJICAP™ works with experienced CDMO partners that support programs intended for global development. Partner selection considers manufacturing experience, quality systems, and regulatory expectations relevant to the target market, including FDA, EMA, and PMDA requirements where applicable.
Integrated Quality Systems
AJICAP™ maintains technical oversight throughout development and technology transfer activities. Quality expectations, analytical requirements, and process information are communicated to manufacturing partners to support consistent execution and product quality across development stages.
Our Preferred CDMO Partnerships
Each CDMO brings distinct strengths to the network.
NJ Bio
ADC development and manufacturing from ADC candidate screening through clinical manufacturing, including extensive experience in AJICAP™-enabled ADC production, process development, and technology transfer.
Piramal Pharma Solutions
A pioneer in commercial-scale ADC manufacturing, with experience supporting hundreds of ADC programs and multiple commercial products. Continues to expand global ADC manufacturing capacity.
Ready to move forward?
From first conjugate through Phase 1/2 cGMP clinical supply — one relationship, every stage.
Frequently Asked Questions
Does Aji Bio-Pharma manufacture ADCs in-house?
We provide AJICAP™ conjugation technology and linker technology, as well as process development, analytical support, and technology transfer. GMP manufacturing may be performed by qualified AJICAP™ partner CDMOs or by customer-selected manufacturing partners. This flexible model allows customers to choose the manufacturing strategy that best fits their development needs.
Can I use my own CDMO with AJICAP™?
Yes. Customers may work with their preferred CDMO partner. AJICAP™ supports process development and technology transfer and can work with customer-selected manufacturing partners. AJICAP™ partner CDMOs are also available for customers seeking established ADC manufacturing capabilities and prior AJICAP™ technology transfer experience.